Pharmaceutical preparations company · DE · FY ends Dec · Revenue $12M · 3.23% margin
Operating margin is thin at 1.85%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 25.2% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$12K. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$12M
▼ -25.2% YoY
Net Income (TTM)
-$8M
▼ -16.1% YoY
Op. Margin
3.23%
▲ +13.2pp YoY
ROIC
1.27%
▲ +5.3pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$12K
▲ +99.5% YoY
Op. Cash Flow (TTM)
-$634K
▲ +99.5% YoY
Net Debt
$27M
Cash & Equiv.
$1M
5Y CAGR: -11.7%
Continue Research